Maverick Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-11,420
| Closed | -$2.1M | – | 862 |
|
|
2021
Q2 | $2.1M | Sell |
11,420
-18,889
| -62% | -$3.47M | 0.02% | 163 |
|
|
2021
Q1 | $4.64M | Buy |
+30,309
| New | +$4.64M | 0.04% | 76 |
|
|
2020
Q4 | – | Sell |
-10,959
| Closed | -$1.25M | – | 813 |
|
|
2020
Q3 | $1.25M | Sell |
10,959
-2,475
| -18% | -$283K | 0.02% | 220 |
|
|
2020
Q2 | $1.51M | Buy |
13,434
+11,315
| +534% | +$1.27M | 0.03% | 218 |
|
|
2020
Q1 | $190K | Buy |
+2,119
| New | +$190K | ﹤0.01% | 424 |
|
|
2015
Q3 | – | Sell |
-1,600
| Closed | -$289K | – | 133 |
|
|
2015
Q2 | $289K | Buy |
1,600
+250
| +19% | +$45.2K | ﹤0.01% | 58 |
|
|
2015
Q1 | $234K | Buy |
+1,350
| New | +$234K | ﹤0.01% | 118 |
|